NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Dawn Biopharma

Dawn Biopharma

New York City, New Yorklinkedin.com

Overview

Dawn Biopharma is a biopharmaceutical investment platform controlled by KKR's Healthcare Strategic Growth Fund II that provides flexible capital to companies developing innovative medicines and therapies.

Year Founded

2022

Portfolio Companies

1

Investments

Dawn Biopharma investments
CompanyDateStageLead
AdcytherixOct 2025Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year Founded2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.